DUXAP8 and breast cancer: In conclusion, our study uncovered a novel role of lncRNA DUXAP8 in augmenting the radioresistance in BC by activating PI3K/AKT/mTOR pathway and repressing E-cadherin and RHOB expression through targeting EZH2.